DaVita
DVA
$99.28
Share price
0.12%
Change (1 day)
3.61%
Change (1 year)
Categories
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.
EPS for DaVita (DVA)
EPS in 2023 (TTM): $5.58
According to DaVita's latest financial reports the company's current EPS (TTM) is $5.58. In 2022 the company made an earnings per share (EPS) of $5.98 a decrease over its 2021 EPS that were of $9.28.
EPS history for DaVita from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $5.58 | -6.69% |
| 2022 | $5.98 | -35.56% |
| 2021 | $9.28 | 44.1% |
| 2020 | $6.44 | 19.7% |
| 2019 | $5.38 | 540.48% |
| 2018 | $0.84 | -76.07% |
| 2017 | $3.51 | -19.31% |
| 2016 | $4.35 | 242.52% |
| 2015 | $1.27 | -62.87% |
| 2014 | $3.42 | 13.43% |
| 2013 | $3.01 | 8.45% |
| 2012 | $2.78 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Universal Health Services
UHS | $9.50 | 70.25% | 🇺🇸 USA |
 LabCorp LH | $11.07 | 98.39% | 🇺🇸 USA |
 Tenet Healthcare THC | $3.94 | -29.39% | 🇺🇸 USA |
 Pediatrix Medical Group MD | $1.22 | -78.18% | 🇺🇸 USA |